Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>Products>This Product

You asked for faster speed, less cross-talk, easy operation and low cost … Shimadzu Listened!

Product Image
Product Description

To increase lab efficiency, researchers are constantly challenged to detect more target analytes with greater sensitivity in hundreds of samples per day. To meet this challenge, Shimadzu has developed the LCMS-8030, which combines the power of triple quadrupole mass spectrometry with unmatched speed to provide the ideal complement to its UHPLC systems.

Speed Beyond Comparison
The LCMS-8030 features ultrafast multiple reaction monitoring (MRM) transitions (dwell times of 1msec and pause times of 1msec), enabling data acquisition with up to 500 different channels per second. The improvements to the electronics provide ultrafast mass spectrum measurement speeds of 15,000 u/sec without sacrificing sensitivity or resolution, allowing full spectrum scans within a series of MRM measurements, and ultra-fast polarity switching (15msec) for the most information without signal deterioration.

Patented UFsweeper® technology accelerates ions out of the collision cell by forming a pseudo-potential surface. The result is high-efficiency collision-induced dissociation (CID) and ultra-fast ion transport, reducing the sensitivity losses and cross talk observed on other systems. In addition, higher radio frequency (RF) power capability minimizes pauses between each transition.

When coupled with Shimadzu’s Nexera UHPLC, the LCMS-8030 can provide reliable and accurate detection of peaks only one-second wide, maximizing UHPLC performance. With a polarity switching time of just 15 msec, ultra-fast triple quadrupole measurement time is now a reality.

Integrated Approach to Ultrafast Mass Spectrometry
The combination of the LCMS-8030 with Nexera also brings together the latest hardware on the same platform. The unified platform provides unmatched qualitative and quantitative analysis, increased productivity, and accelerated workflows for high-throughput analysis. Automated optimization of analytical conditions for each quantitative target compound, which is the key to high-sensitivity analysis, allows unattended, overnight operation. In addition, all software operations are handled seamlessly, reducing PC conflicts and the need for user intervention.

Easy Maintenance
With the LCMS-8030, maintenance has never been easier or more accessible. Its robust design allows maximum uptime, resulting in a system that can handle most complex matrices. Maintenance of the desolvation line without breaking vacuum minimizes instrument downtime.

Product You asked for faster speed, less cross-talk, easy operation and low cost … Shimadzu Listened!
Company Shimadzu
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Shimadzu Scientific Instruments 7102 Riverwood Drive, Columbia, MD 21046 USA

Tel: +1 410-381-1227
Fax: +1 410-381-1222

Scientific News
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Chemical Design Made Easier
Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Fighting Pain with Ketamine
Researchers at the Texas A&M Health Science Center are using ketamine, a drug that already exists as an anesthetic, to treat pain.
Possible New Treatment for Neurodegenerative Diseases Found
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.

Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos